Guangdong Weitai Biotechnology Co., Ltd., established on 2015-11-04, The scope of business includes research on stem cell and immune cell biotechnology and its biological products,to develop,Production,Sales and Applications;Collection of stem cells and immune cells,Storage and custody services;Research on genetic detection technology and its reagent products and instruments,to develop,Production,Sales;Gene drug development;Cell and gene-related technology transfer,Technical Services,technical consulting,Technical Training;Clinical Laboratory Services;Biomedical Technology Research;Provide management program services for medical institutions;Import and export,Technology Import and Export.Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;Natural science research and experimental development;Technology intermediary service;Quality inspection technical service;outpatient department(Place);nursing home;trade agent;Wholesale of cosmetics and hygiene products;Western medicine wholesale;Wholesale of nutrition and health products;Wholesale of medical supplies and equipment;Retailing of cosmetics and hygiene products;Nutrition and Supplement Retailing;Biopharmaceutical Manufacturing;Cosmetic Manufacturing;Health food manufacturing;Nutritional Food Manufacturing;dairy manufacturing;Manufacturing of chemical raw materials;Chemical Reagent and Auxiliary Manufacturing.(above production,Manufacturing items limited to branch operations)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Boya Stem Cell Technology Co. Ltd. develops stem cell technology products. The company is headquartered in Wuxi, China.

Accurate International is engaged in the research and development of regenerative medicines based on the four centers of organoid tissue and disease models. clinical medicine transformation, big data sharing, and smart device development.

Specialites Pet Food SASU produces animal feeds. The company was founded on January 6, 1998 and is headquartered in Elven, France.

Regend Therapeutics focuses on the human organ regenerative medicine business and is a global leader in this field. Its core product REGEND001 cell preparation has been accepted by the State Food and Drug Administration and is the world's first autologous stem cell product for respiratory diseases. The company is also the first company in China to be registered by the National Health and Health Commission and the Food and Drug Administration, and is allowed to conduct clinical research on stem cells (Registration No.: CMR-20161214-1002). It is also the first batch of key research and development programs of the Ministry of Science and Technology. And companies that transform research topics. At present, the company has passed ISO9001:2008 quality management system certification, and the stem cell preparation has passed the China Metrology Accreditation (CMA), China Conformity Assessment Committee (CNAS) and IAF International Mutual Recognition. All clinical programs of Jimmy Suisheng are strictly in accordance with the regulations of the National Health Care Commission and the Food and Drug Administration, and are registered with the National Trial Global Database of the National Institutes of Health.

Danwang Medical provides clinical transformation technology services to regenerative medicine for disease diagnosis and treatments. They also provide organoid drug sensitivity testing, organoid disease models, organoid drug development, and organoid chips. Danwang Medical is committed to applying the most recent clinical transformation technology of regenerative medicine to disease diagnosis and treatment, new drug screening, tumor marker development and identification, and other areas in order to provide clinical personalized treatment technology and accurate, efficient, and high-quality organoids Model to new drug research and development enterprises.

Wuxi Saibiman Biotechnology Co., Ltd., established on 2017-01-17, Business scope includes biotechnology,Technology development in the field of medical science and technology,technical consulting,Technical Services,technology transfer,Cell Storage Technology Services,Business Management Consulting(Does not include investment advice),Sales of laboratory equipment and consumables,Leasing of own equipment,Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Part of Cellular Biomedicine Group, Inc., Shanghai Cellular Biopharmaceutical Group Ltd. is a company headquartered in China. The firm develops therapies for cancer and degenerative diseases.

Guangzhou Qihui Biotechnology Co., Ltd., established on 2015-05-22, Business scope includes sales of chemical products(No licensed chemical products);Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;Development of Human Gene Diagnosis and Therapy Technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;software development;Technology intermediary service;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Import and export;Class III medical device business;

Shanghai Personal Biotechnology Co. Ltd. manufactures nutritional beauty products. Its products include high throughput sequencing, conventional molecular biology services, and conventional sequencing and synthesis. The company was founded in April 2011 and is headquartered in Shanghai, China.

Beijing Hongxin Stem Cell Biotechnology Co., Ltd., established on 2015-05-22, Business scope includes stem cell storage,Stem Cells and Biomaterials,Stem Cell and Tissue Engineering Products,stem cell therapy,regenerative medicine,Genetic Testing,Biological product,biological reagent,biomedicine,Technology development of immune cells,technology transfer,Technical Services,Technology Promotion;ProductionIclass of medical devices;SalesI,IIclass of medical devices;sell cosmetics;Technology Import and Export;Medical Research and Experimental Development;Sales of Class III medical devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Shenzhen Unizhikang Medical Technology Co., Ltd., established on 2014-06-25, Business scope includes general business items:Health and wellness management consulting(Does not contain medical behavior);Domestic Trade,Operating import and export business.Metering technical service;Professional Design Services;graphic design;internet sales(Except for products that require a license for sale);Health Care Services(non-medical);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Development of Human Gene Diagnosis and Therapy Technology;Class I Medical Device Leasing;Sales of Class I Medical Devices;Special Equipment Repair;Personal Hygiene Sales.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:medical products,Health products,cosmetic,R&D and sales of electronic products,Production.Inspection and testing service;Class II Medical Device Leasing;Class III Medical Device Leasing;Sales of Class II Medical Devices;Internet Information Service for Medical Devices;Technology Import and Export;Insurance Brokerage.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments);food sales(Only sell prepackaged food).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Youkang Hengye Biotechnology (Beijing) Co., Ltd. is a private company headquartered in China that operates as a biotechnology company.

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, production and sales of medical devices and pharmaceuticals. It offers orthopedics, medical aesthetics, wound healing, hemostasis, ophthalmology and anti-adhesion products. The company mainly offers intraocular lens (IOL), ophthalmology and optometry end products, medical sodium hyaluronate, medical chitosan, medical collage sponge, rhEGF amd other related products. Shanghai Haohai Biological Technology was founded on January 24, 2007 and is headquartered in Shanghai, China.

Shanghai Qisheng Biologics Co., Ltd., established on 1992-05-27, Business scope includes biological reagents,biologics,biomaterials,Manage the export business of the company's self-produced products and technologies and the machinery and equipment required by the company,spare parts,Import business of raw and auxiliary materials and technologies(Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of),The enterprise includes the member enterprises controlled by the enterprise,cosmetic,Daily Chemicals(Removal of hazardous chemicals),sales of hygiene products,Production and sales of medical devices. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Zhongyuan Xiehe Biological Cell Storage Service (Tianjin) Co., Ltd., established on 2016-10-17, Business scope includes cell tissue storage services;biology,Cell tissue storage technology development,consult,Serve,transfer;Import and export of goods and technology;Cell Culture Media Aliquots,Wholesale and retail.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)